Iontophoretic transdermal delivery of buspirone hydrochloride in hairless mouse skin

AAPS Journal

Volumn 5, Issue 2, 2003, Pages

  Al Khalili, Mohammad ^a   Meidan, Victor M ^b   Michniak, Bozena B ^b  

^a UNIVERSITY OF SOUTH CAROLINA   (United States)

^b RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

Buspirone hydrochloride; Gel; Iontophoresis; Terpene; Transdermal

Indexed keywords

EID: 55449107209     PISSN: 15507416     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Balon R. Buspirone in the treatment of separation anxiety in an adolescent boy. J Clin Psychopharmacol. 1994;14:360-361.
2. Ratey JJ, Sovner R, Mikkelsen E, Chmielinski HE. Buspirone therapy for maladaptive behavior and anxiety in developmentally disabled persons. J Clin Psychiatry. 1989;50:382-384.
3. Realmuto GM, August GJ, Garfinkel BD. Clinical effect of buspirone in autistic children. J Clin Psychopharmacol. 1989;9:122-125.
4. Dollery C. Therapeutic Drugs. 2nd ed. Vol 1. Edinburgh, Scotland: Churchill Livingston; 1999.
5. Valenta C, Siman U, Kratzel M, Hadgraft J. The dermal delivery of lignocaine: influence of ion pairing. Int J Pharm. 2000;197:77-85.
6. Smith JC, Irwin WJ. Ionisation and the effect of absorption enhancers on transport of salicylic acid through silastic rubber and human skin. Int J Pharm. 2000; 210: 69-82.
7. Anliker M, Maibach HI, Singh P. Transdermal iontophoresis and solute penetration across excised human skin. Curr Prob Dermatol. 1995;22:184-188.
8. Guy RH. Iontophoresis, recent developments. J Pharm Pharmacol. 1998;50:371-374.
9. Banga AK. Electrically Assisted Transdermal and Topical Drug Delivery. London, England: Taylorand Francis; 1998.
10. Guy RH, Kalia YN, Delgado-Charro MB, Merino V, Lopez A, Marro D. Iontophoresis: electrorepulsion and electroosmosis. J Control Release. 2000; 64:129-132.
11. Cardoso SG, Schapoval EE. Stability assay of buspirone hydrochloride in tablets. Pharmazie. 1998;53:349-351.
12. Wearley L, Liu JC, Chien YW. Iontophoresis-facilitated transdermal delivery of verapamil, II: factors affecting the reversibility of skin permeability. J Control Release. 1989;9:231-242.
13. Padmanabhan RV, Phipps JB, Lattin GA, Sawchuk RJ. In vitro and in vivo evaluation of transdermal iontophoretic delivery of hydromorphone. J Control Release. 1990;11:123-135.
14. Miller LL, Smith GA. Iontophoretic transport of acetate and carboxylate ions through hairless mouse skin: cation exchange membrane model. Int J Pharm. 1989;49:15-22.
15. Bellantone NH, Rim S, Francoeur ML, Rasadi B. Enhanced percutaneous absorption via iontophoresis, I: evaluation of an in vitro system and transport of a model compound. Int J Pharm. 1986;30:63-72.
16. Sage BH. Iontophoresis. In: Smith EW, Maibach HI, eds. Percutaneous Penetration Enhancers. Boca Raton, FL: CRC; 1995:361-365.
17. Hladky SB, Haydon DA. Ion transfer across lipid membranes in the presence of gramicidin A, I: studies of the unit conductance channel. Biochim Biophys Acta. 1972;274:294-312.
18. Lauger P. Ion transport through pores: a rate-theory analysis. Biochim Biophys Acta. 1973;311:423-441.
19. Yoshida NH, Roberts MS. Role of conductivity in iontophoresis, II: anodal iontophoretic transport of phenylethylamine and sodium across excised human skin. J Pharm Sei. 1994;83:344-350.
20. Yoshida NH, Roberts MS. Prediction of cathodal iontophoretic transport of various anions across excised skin from different vehicles using conductivity measurements. J Pharm Pharmacol. 1995;47:883-890.
21. Hinz RS, Lorence CR, Price M, Guy RH, Kim A. Convective solvent flow across the skin during iontophoresis. Crit Rev Toxicol. 1993;23:171-235.
22. Glikfeld P, Guy RH, Burnette RR. Characterization of the permselective properties of excised human skin during iontophoresis. Pharm Res. 1993;10:1751-1755.
23. Guy RH, Golden GM, Mak VH, Francoeur ML, Delgado-Charro MB. Characterization of convective solvent flow during iontophoresis. J Invest Dermatol. 1994;103:233-239.
24. Hirvonen J, Kalia YN, Guy RH. Transdermal delivery of peptides by iontophoresis. Pharm Res. 1996;13:1765-1769.
25. Langer R, Brown L, Edelman E. Controlled release and magnetically modulated release systems for macromolecules. Methods Enzymol. 1985;112:399-422.
26. Vazquez MJ, Perez-Marcos B, Gomez-Amoza JL, Martinez-Pacheco R, Concheiro A. Influence of technological variables on release of drugs from hydrophilic matrices. Drug Dev Ind Pharm. 1992;18:1355-1375.
27. Doliwa A, Santoyo S, Ygartua P. Effect of passive and iontophoretic skin pretreatments with terpenes on the in vitro skin transport of piroxicam. Int J Pharm. 2001;229:37-44.
28. Doliwa A, Santoyo S, Ygartua P. Transdermal iontophoresis and skin retention of piroxicam from gels containing piroxicam: hydroxypropyl-beta-cyclodextrin complexes. Drug Dev Ind Pharm. 2001;27:751-758.
29. Fang JY, Hsu LR, Huang YB, Tsai YH. Evaluation of transdermal iontophoresis of enoxacin from polymer formulations: in vitro skin permeation and in vivo microdialysis using Wistar rat as an animal model. Int J Pharm. 1999;180:137-149.
30. Fang JY, Sung KC, Lin HH, Fang CL. Transdermal iontophoretic delivery of diclofenac sodium from various polymer formulations: in vitro and in vivo studies. Int J Pharm. 1999;178:83-92.
31. Doelker E. Water-swollen cellulose derivatives in pharmacy. In: Pappas NA, ed. Hydrogels in Medicine and Pharmacy. Vol 2: Polymers. Boca Raton, FL: CRC; 1987:115-160.
32. Chu DL, Chiou HJ, Wang DP. Characterization of transdermal delivery of nefopam hydrochloride under iontophoresis. Drug Dev Ind Pharm. 1994;20:2775-2785.
33. Fang JY, Huang YB, Wu PC, Tsai YH. Transdermal iontophoresis of sodium nonivamide acetate, II: optimization and evaluation on solutions and gels. Int J Pharm. 1996;145:175-186.
34. Brouneus F, Karami K, Beronius P, Sundelof L. Diffusive transport properties of some local anesthetics applicable for iontophoretic formulation of the drugs. Int J Pharm. 2001;218:57-62.
35. Fang JY, Kuo CT, Huang YB, Wu PC, Tsai YH. Transdermal delivery of sodium nonivamide propionate by iontophoresis. Biol Pharm Bull. 1998;21:1117-1120.
36. Ganga S, Ramarao P, Singh J. Effect of Azone on the iontophoretic transdermal delivery of metoprolol tartrate through human epidermis in vitro. J Control Release. 1996;42:57-64.
37. Kalia YN, Guy RH. The electrical characteristics of human skin in vivo. Pharm Res. 1995;12:1605-1613.
38. Williams AC, Barry BW. Terpenes and the lipid-protein-partitioning theory of skin penetration enhancement. Pharm Res. 1991;8:17-24.
39. Okabe H, Obata Y, Takayama K, Nagai T, Quan DY. Percutaneous absorption enhancing effect and skin irritation of monocyclic monoterpenes: enhancing effect of piperidone derivatives on the percutaneous absorption of indomethacin. Drug Des Deliv. 1990;6:229-238.
40. Moghimi RH, Williams AC, Barry BW. A lamellar matrix model for stratum corneum intercellular lipids, V: effects of terpene penetration enhancers on the structure and thermal behaviour of the matrix. Int J Pharm. 1997;146:41-54.
41. El-Kattan AF, Asbill CS, Kim N, Michniak BB. The effects of terpene enhancers on the percutaneous permeation of drugs with different lipophilicities. Int J Pharm. 2001;215:229-240.
42. Okabe H, Takayama K, Ogura A, Nagai T. Effect of limonene and related compounds on the percutaneous absorption of indomethacin. Drug Des Deliv. 1989;4:313-321.
43. Arellano A, Santoyo S, Martin C, Ygartua P. Enhancing effect of terpenes on the in vitro percutaneous absorption of diclofenac sodium. Int J Pharm. 1996;145:130-141.